Seawith is a biotechnology startup developing cell-cultured steak from seaweed. Yo.od, a low-iodine seaweed developed by Seawith, is aimed at consumers with low iodine resistance and high iodine sensitivity. Seawith creates its own culture media from microalgae, which provides the benefits of algae nutrition while also being much cheaper due to the abundance of microalgae.
Opticho develops ultrasound microscopes to aid in preclinical and clinical research. The company focuses on the commercialization of ultrasonic microscopes, which are comprised of an ultrasound diagnostic device and a laser device and are based on optical technology that employs photoacoustic effects to image blood vessels, particularly peripheral blood vessels, allowing researchers to diagnose peripheral vascular diseases.
LaSemilla is an ag-tech company that aims to alleviate the food crisis caused by the global climate crisis. The company offers a sustainable food production platform as well as crop development that responds to climate change by using cutting-edge biotechnology to make them more resistant, allowing firms to increase food security through technology.
Galux provides molecular design technology focusing on discovering and developing novel drugs for incurable and rare diseases using its AI-based drug design platform technologies.
CasCure Therapeutics develops personalized chemotherapy technology. The company uses artificial intelligence algorithms and deep learning technology for pipeline devices, such as Platform C for developing precision cancer medicines and Platform H for anti-cancer drugs, to provide medical professionals with a solution to cure cancer.
GenEdit was founded to transform the delivery of gene therapies and enable the next generation of non-viral, gene editing-based therapeutics. GenEdit’s proprietary technology, NanoGalaxy™ platform solves current delivery challenges by systematically screening its nanoparticle library and providing safer and efficient delivery to target tissues. The company's tool makes therapeutic gene editing possible and is easier to use, faster and more accurate than previous gene-editing techniques and thus has the potential for a wide range of therapeutic applications, enabling physicians to cure incurable genetic diseases.
Tomocube’s is dedicated to delivering products that can enhance biological and medical research via novel optical solutions that can assist Tomocube in understanding, diagnosing, and treating human diseases. Current optical microscopes only provide users with a 2D view of their sample. To get a 3D view, users must use expensive and invasive electron or confocal microscopes, which require extensive pre-preparation of samples and are not amenable to dynamic samples such as live cells. Their platform enables researchers to measure nanoscale, real-time, dynamic images of individual living cells without the need for sample preparation.
Seawith is a biotechnology startup developing cell-cultured steak from seaweed. Yo.od, a low-iodine seaweed developed by Seawith, is aimed at consumers with low iodine resistance and high iodine sensitivity. Seawith creates its own culture media from microalgae, which provides the benefits of algae nutrition while also being much cheaper due to the abundance of microalgae.
GI Innovation is a South Korean bio-venture company, integrating basic science and translational innovation in developing biologics for patients around the world. GI Innovation’s strategic focus is on immuno-oncology and inflammation/immunology diseases. GI Innovation has established GI-SMART platform technology that is designed to accelerate the development of biologics through the efficient optimization of multi-targeting fusion protein therapeutics with high quality and high productivity.
PharmCADD develops a new drug development platform that uses AI-based protein structure prediction algorithms, MD simulation, and quantum calculation to enable faster drug design. PharmCADD's products include Pharmulator, a consolidated drug discovery platform comprised of five core modules such as protein/RNA 3D structure prediction, drug generation, virtual screening, quantum calculation, and toxicity prediction to generate candidates with higher potential; and PharmVAC, a vaccine development platform that provides optimal solutions to users and clients to design, analyze, and visualize more probable RNA sequences for any vaccine candidates.
Idience a drug development company development and commercialization of innovative new medicines and drive innovation and transform the cancer treatment, also automatically detects and classifies various disorder on multiple imaging modalities, they are using a revolutionary form of artificial intelligence to teach computer to read medical image and automatically provide structured reports.
JD Bioscience is a drug development company that provides medical research solutions for metabolic disorders.
Elgen Therapeutics
Seed Round in 2021
Elgen Therapeutics develops an anti-cancer therapy platform. The company's platform creates drugs based on a new epigenetic target and the discovery of a new E3 ligase ligand, allowing medical professionals to find treatment for cancer.
RevoSkectch is a molecular diagnostics company focused on developing digital PCR platform with unique spin partitioning technology. revoskectch is to provide the simplest and affordable digital PCR solutions to life science industry.
PharmCADD develops a new drug development platform that uses AI-based protein structure prediction algorithms, MD simulation, and quantum calculation to enable faster drug design. PharmCADD's products include Pharmulator, a consolidated drug discovery platform comprised of five core modules such as protein/RNA 3D structure prediction, drug generation, virtual screening, quantum calculation, and toxicity prediction to generate candidates with higher potential; and PharmVAC, a vaccine development platform that provides optimal solutions to users and clients to design, analyze, and visualize more probable RNA sequences for any vaccine candidates.
ROKIT Healthcare provides hardware, software, and application support. Their custom fabrication technologies deliver solutions to the design, creation, and applications of three-dimensional systems. They provide suffering patients and humans with a hyper-personalized medical organ regeneration solution. They apply artificial intelligence and 3d bioprinting technology to regenerate the skin and cartilage organs through surgery for patients.
Huons is a South Korean company established in 1965, specializing in the manufacturing and sale of high-quality pharmaceutical products. It is recognized for developing the first local anesthetics and plastic ampoule injections in Korea. The company operates through three main divisions: pharmaceuticals, medical devices, and cosmetics. The pharmaceutical division focuses on ethical drugs, while the medical devices division develops products for the safe preparation of blood components. Additionally, Huons offers a range of cosmetic products, including cleansers, creams, and sunscreens. With a strong commitment to quality control and ongoing research and development, Huons exports its products to around 30 countries across North and South America, Europe, Asia, and Africa.
Sugentech is a total platform company. They provide personalized diagnosis by utilizing commercialized platforms based on bio, nano, and IT convergence technologies. They develop the automated multi-immunoblot device and supplies. They developed a diagnosis kit and automatic analysis devices.
Medipixel is a MedTech startup that aims to contribute to the improvement of the quality of human life by innovating the way we diagnose diseases and controlling surgical robots with the power of AI. Consisting of a group of AI experts in computer vision, deep learning, and reinforcement learning, Medipixel conducts research and product development for lung cancer diagnosis and coronary intervention robots together with the best healthcare professionals in Korea such as Seoul Asan Medical Center. In November 2018, MediPixel won the championship in the QuickFire Challenge hosted by Johnson & Johnson. MediPixel currently offers three solutions for intervention surgeons: 1. An AI Based Diagnosis Solution makes it possible for doctors to spot lesions while performing a coronary angiography, perform segmentation of the vessel in question within just one second and analyze the lesion’s status. 2. A Guide & Planning Solution clearly visualizes the hidden part of the coronary artery to make doctors perform guidewire manipulation with more ease and confidence, which is quite useful especially in case of CTO. Furthermore, the solution frees doctors from the need to use contrast -- this is important because contrast can cause potentially fatal reactions in 5 to 10% of patients. 3. An Automated Navigation Engine automates navigation through coronary arteries. Once the destination is reached, it controls a robotic unit by giving the most appropriate real-time commands in its existing situation, thus delivering devices such as guidewire to the destination in the most efficient way. We're open to any candidates who are excited to apply their knowledge and skill in deep learning to real-world medical data and surgery robots. Do you have any questions? Email us at contact@medipixel.io
Curiox is a bioinstrumentation company spun out of the Agency for Science, Technology, and Research (A*STAR) in Singapore. Curiox has become a leader in the development and commercialization of innovative assay platforms based on its expertise in surface chemistry and engineering. Curiox’s vision is to accelerate the progress of life sciences, drug discovery and diagnostics through the miniaturization and improved automation of bioassays.
Alodokter is a digital health platform that provides an end-to-end digital solution to patients including telemedicine, doctors, and others. It also provides credible information, supportive communities, and in-depth reference material about health subjects.
StemLab is a Korean biotech company that is developing therapeutic solutions to treat diseases and injuries that have no alternative cures. In particular, it develops cells that can regenerate the central nervous system tissues based on its cell reprogramming technology that transforms somatic cells into stem cells. Stemlab’s cell reprogramming technology takes fully differentiated cells and reprograms them into neural stem cells, allowing them to obtain the stem cells necessary to create stem cell therapies. It thus avoids the ethical issues concernng embryonic stem cell research. Also, its reprogrammed neural stem cells have expansion capability comparable to neural stem cells derived from pluripotent stem cells. And since StemLab obtains somatic cells through urine, harvesting is much less invasive than using cells obtained using other invasive means. StemLab's technology is backed up with 18 patents for original technology related to stem cell treatments and has three patents for application technology, with another five pending. Its initial clinical programs will involve patients with spinal cord injury (SCI) and Amyotrophic Lateral Sclerosis (ALS) or (Lou Gehrig's Disease.
Hisense Bio offers treatment for intractable dental diseases. They provide research on original technology for tooth development and dentin regeneration. They developed physiological dentin regeneration technology and periodontal ligament regeneration technology based on basic dental research . They offer treatment of intractable dental diseases such as tooth decay, dental hypersensitivity, tooth decay, dental caries, and periodontal disease.
Jeisys Medical is a medical device manufacturer. Their products include ultra cell q+ system, the V system, lipocel, acgen, tri-beam premium, edge one, smoothcool, and ultracel. They provide medical and aesthetic treatments that include skin rejuvenation, lifting and tightening, pigmentation treatments, fat reduction, acne, and more.
Tomocube’s is dedicated to delivering products that can enhance biological and medical research via novel optical solutions that can assist Tomocube in understanding, diagnosing, and treating human diseases. Current optical microscopes only provide users with a 2D view of their sample. To get a 3D view, users must use expensive and invasive electron or confocal microscopes, which require extensive pre-preparation of samples and are not amenable to dynamic samples such as live cells. Their platform enables researchers to measure nanoscale, real-time, dynamic images of individual living cells without the need for sample preparation.
Noul offers solutions for chronic and systemic problems in healthcare. Noul adapts invitro diagnostics to improve medical access with innovative diagnostic solutions. It focuses on enhancing human health by contributing to the eradication of infectious and non-infectious diseases that are considered as some of the threats to global health.
Genoplan's mission is to democratize healthcare by harnessing the power of population genomics and deep learning. The company is dedicated to making genomics widely accessible, offering tools and analytics that empower individuals to make informed health decisions. Ultimately, Genoplan aims to contribute to the advancement of precision medicine while helping people take control of their well-being.
SCM Lifescience was established in 2014 with the vision of 'developing treatment options for difficult to treat diseases to provide a new source of hope for patients and contribute to the welfare of humanity as a whole' using proprietary stem cell isolation technology and stem cell production technology.
Y-Biologics is specialized in antibody drug since its inception has focused on research and development. They have successfully constructed the unique human antibody library Y-max ABL and new dual antibody platform technology ALiCE. Based on this, they have developed various antibody drugs and become a leading company in the global immuno-chemotherapeutic drug market They are doing their best to leap forward.
Cellid is a research and development bioventure company. The company is developing immunotherapeutic vaccines, CeliVax. The CeliVax is a personalized vaccine which uses patient's own cells.
1) What we do • We develop a deep learning based QA(Question Answer) system that understands the true intention of the question and provide a Unique Correct Answer 2) Why • AI based Smart machines are penetrating into our everyday lives, there are signals of paradigm shift from the traditional web search system to QA system. 3) Market Size • Globally expecting a $50bn market size by year 2025 (+50% YoY). • 50% of all searches will be done by voice searches by year 2020. 4) Technology • We have core technologies in IR(Information Retrieval), Triple, MRC(Machine Reading Comprehension), Paraphrasing, NLU/NLP(Natural Language Understanding/Processing) etc. 5) Core Competency • Our system is different to the existing system because we have a high accuracy, self expansion of KB(knowledge base), low GPU cost, quick response. • This is the reason why we have the globally the first deep learning based QA commercial version in Korean. • We have experience in a commercial version of sematic search which has similar logics with QA system and also have multi-language web-search experience as well. • Strong team with CEO having +20yrs of related work experience. 6) Target Markets • Connected Cars, Smart Speakers, Home IoT, Home Robots, Smart Toys, Personal Assistants, Chatbot Apps, Intranet, KMS. 7) Business Model • Planning B2C penetration through B2B2C Alliance and set for global expansion with multi-language support. 8) References • B2B projects with some major TELCOs in Korea, such as LG and Korea Telecom, and also with big ship building industries and financial institutions. 9) Competitors • Competitors have QA systems based on either Rule-based or Inference based which has limitations on commercialization. 10) Team • CEO: Pioneer in the search engine industry with +20 years of experiences, deep learning expert • Total member of 27 (22 QA specialists) (hiring currently more)
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.